Reply to Varghese et al.'s response to Wu et al. - "Cost effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong"

Hum Vaccin Immunother. 2016 Oct 2;12(10):2681-2684. doi: 10.1080/21645515.2016.1209279.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cost-Benefit Analysis*
  • Hong Kong
  • Humans
  • Infant
  • Malaysia
  • Pneumococcal Infections
  • Pneumococcal Vaccines
  • Vaccination*

Substances

  • Pneumococcal Vaccines